当前位置: 首页 > 期刊 > 《中外健康文摘·新医学学刊》 > 2008年第1期
编号:11587590
蛋白酶体抑制剂与恶性肿瘤的关系(3)
http://www.100md.com 2008年1月1日 《中外健康文摘·新医学学刊》 2008年第1期
     [6] Muyang L,Delin C,Ariel S,et a1.Deubiquitination of p53 by HAUSP is all important pathway for p53 stabili,action[J].Nature,2002,416(6881):648-653

    [7] Giovanni D,Angela H,Frank M C,et al.Infetion Imunity,2000,68(6):3097-3102

    [8] Traidej M,Chen L,Yu D,et a1.The roles of E6-AP and MDM2 in p53 regulation in human papillomavirus-positive cervical cancer cells [J].Antisense Nucleic Acid Drug Dev,2000,10:17-27

    [9] Hagan RC,Ohh M,David G,et a1.Myc-enhanced expression of Cull promotes

    ubiquitin-dependent proteolysis and cell cycle progression [J].Genes Dev,2000,14(17):2l85-2191

    [10] Masuda TA,Inoue H,Sonoda H,et a1.Clinical and biological sign ificance of S-phase kinase-associated protein 2(Skp2)gene expression in gastric carcinoma:modulation of m alignant phenotypeby Skp2 overexpression,possibly via p27 proteolysis [J].Cancer Res,2002,62(13):3819-3825

    [11] Farhana L,Dawson M,Rishi AK,et a1.Cyclin B and E2F-1 expression in prostate carcinoma cels treated with the novelretinoid CD437 are regulated by the ubiquitin mediated pathway [J].Cancer Res,2002,62(13):3842-3849

    [12]Bhatia N,Herter JR,Slaga TJ,et a1.Mouse homologue of HOS is overexpressed in skin tumors and implicated in constitutive activation of NF-kappaB[J].Oncogene,2002,21(10):1501-1509, http://www.100md.com(马 宁 刘子玲)
上一页1 2 3